Your email has been successfully added to our mailing list.

×
0 0.000467781546017916 0.00385919775464856 -0.000116945386504562 0.00537948777920704 0.0101157759326394 0.00929715822710796 0.0219857326628464
Stock impact report

Variant-adapted COVID vaccine wins first approval in Britain [Financial Post (Toronto, Ontario, Canada)]

Moderna, Inc. (MRNA) 
Last moderna, inc. earnings: 2/26 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: marinabio.com/investor-relations
Company Research Source: Financial Post
Advertisement The UK medicines regulator (MHRA) approved the so-called bivalent vaccine made by U.S. drug company Moderna as a booster for adults. The agency’s decision was based on clinical trial data that showed the booster triggered “a strong immune response” against both Omicron (BA.1) and the original 2020 virus, it said. The MHRA also cited an exploratory analysis in which the shot was found to generate a good immune response against the currently dominant Omicron offshoots BA.4 and BA.5. No serious safety concerns were identified with this new formulation, the agency added. Now approval has been secured, Britain’s Joint Committee on Vaccination and Immunisation (JCVI) will advise on how the vaccine should be deployed in the country. While existing COVID-19 vaccines continue to provide good protection against hospitalization and death, vaccine effectiveness has taken a hit as the virus has evolved. “The first generation of COVID-19 vaccines being used in the UK continue t Show less Read more
Impact Snapshot
Event Time:
MRNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for MRNA alerts
Opt-in for
MRNA alerts

from News Quantified
Opt-in for
MRNA alerts

from News Quantified